FDA Approval of Aducanumab Divided the Community but Also Connected and United It.
作者信息
Hooker Jacob M
出版信息
ACS Chem Neurosci. 2021 Aug 4;12(15):2716-2717. doi: 10.1021/acschemneuro.1c00393. Epub 2021 Jul 6.
PMID:34228436
Abstract
摘要
相似文献
1
FDA Approval of Aducanumab Divided the Community but Also Connected and United It.
ACS Chem Neurosci. 2021 Aug 4;12(15):2716-2717. doi: 10.1021/acschemneuro.1c00393. Epub 2021 Jul 6.
2
Revisiting FDA Approval of Aducanumab.
N Engl J Med. 2021 Aug 26;385(9):769-771. doi: 10.1056/NEJMp2110468. Epub 2021 Jul 28.
3
Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab.
N Engl J Med. 2021 Aug 26;385(9):771-774. doi: 10.1056/NEJMp2111320. Epub 2021 Jul 28.
4
US Food and Drug Administration Approval of Aducanumab-Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials?
JAMA Neurol. 2021 Nov 1;78(11):1307-1308. doi: 10.1001/jamaneurol.2021.3126.
5
Aducanumab and Accelerated Approval: Where Do We Go From Here?
Clin Pharmacol Ther. 2022 Apr;111(4):726-727. doi: 10.1002/cpt.2546. Epub 2022 Feb 16.
6
What to Know About the Alzheimer Drug Aducanumab (Aduhelm).
JAMA Intern Med. 2022 Aug 1;182(8):892. doi: 10.1001/jamainternmed.2022.1039.
7
[Aducanumab and Alzheimer's disease: a critical reflection.].
Recenti Prog Med. 2021 Jul-Aug;112(7):495-498. doi: 10.1701/3638.36183.
8
Aducanumab for Alzheimer's disease: A regulatory perspective.
Pharmacol Res. 2021 Sep;171:105754. doi: 10.1016/j.phrs.2021.105754. Epub 2021 Jul 2.
9
A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease.
J Alzheimers Dis. 2021;83(4):1537-1552. doi: 10.3233/JAD-215065.
10
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Ann Pharmacother. 2022 Jun;56(6):736-739. doi: 10.1177/10600280211050405. Epub 2021 Oct 1.
引用本文的文献
1
Amyloid inhibition by molecular chaperones can be translated to Alzheimer's pathology .
RSC Med Chem. 2023 Mar 21;14(5):848-857. doi: 10.1039/d3md00040k. eCollection 2023 May 25.
2
Role of Aducanumab in the Treatment of Alzheimer's Disease: Challenges and Opportunities.
Clin Interv Aging. 2022 May 18;17:797-810. doi: 10.2147/CIA.S325026. eCollection 2022.
Zotero 插件